Predicting the Progression of Mild Cognitive Impairment Using Machine Learning: A Systematic, Quantitative and Critical Review

Manon Ansart (1) , Stéphane Epelbaum (1) , Giulia Bassignana (2) , Alexandre Bône (1) , Simona Bottani (1) , Tiziana Cattai (3) , Raphäel Couronné (1) , Johann Faouzi (2) , Igor Koval (1) , Maxime Louis (1) , Elina Thibeau-Sutre (1) , Junhao Wen (4) , Adam Wild (1) , Ninon Burgos (5) , Didier Dormont (2) , Olivier Colliot (1) , Stanley Durrleman (1)

1 ARAMIS - Algorithms, models and methods for images and signals of the human brain = Algorithmes, modèles et méthodes pour les images et les signaux du cerveau humain [ICM Paris]
2 ICM - Institut du Cerveau = Paris Brain Institute
3 UNIROMA - Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome]
4 SU - Sorbonne Université
5 CMIC - Centre for Medical Image Computing

We performed a systematic review of studies focusing on the automatic prediction of the progression of mild cognitive impairment to Alzheimer’s disease (AD) dementia, and a quantitative analysis of the methodological choices impacting performance. This review included 172 articles, from which 234 experiments were extracted. For each of them, we reported the used data set, the feature types, the algorithm type, performance and potential methodological issues. The impact of these characteristics on the performance was evaluated using a multivariate mixed effect linear regressions. We found that using cognitive, fluorodeoxyglucose-positron emission tomography or potentially electroencephalography and magnetoencephalography variables significantly improved predictive performance compared to not including them, whereas including other modalities, in particular T1 magnetic resonance imaging, did not show a significant effect. The good performance of cognitive assessments questions the wide use of imaging for predicting the progression to AD and advocates for exploring further fine domain-specific cognitive assessments. We also identified several methodological issues, including the absence of a test set, or its use for feature selection or parameter tuning in nearly a fourth of the papers. Other issues, found in 15% of the studies, cast doubts on the relevance of the method to clinical practice. We also highlight that short-term predictions are likely not to be better than predicting that subjects stay stable over time. These issues highlight the importance of adhering to good practices for the use of machine learning as a decision support system for the clinical practice.

Mots clés: Cognition; Progression; Mild Cognitive Impairment; Alzheimer's disease; Quantitative review; Automatic prediction

Domaines: Machine Learning [stat.ML]; Imagerie médicale; Intelligence artificielle [cs.AI]; Apprentissage [cs.LG]

Manon Ansart, Stéphane Epelbaum, Giulia Bassignana, Alexandre Bône, Simona Bottani, et al.. Predicting the Progression of Mild Cognitive Impairment Using Machine Learning: A Systematic, Quantitative and Critical Review. Medical Image Analysis, 2021, 67, pp.101848. ⟨10.1016/j.media.2020.101848⟩. ⟨hal-02337815v2⟩